Expression and significance of p53 and mdm2 in patients with leukoplakia cancer

被引:0
|
作者
Juan-Juan Cui [1 ]
Xiao-Lan Han [1 ]
Wei-Min Wang [1 ]
机构
[1] Department of Stomatology,the First Affiliated Hospital of Anhui Medical University
关键词
Oral Leukoplakia; p53; mdm2; RT-PCR;
D O I
暂无
中图分类号
R739.8 [口腔、颌面部肿瘤];
学科分类号
100214 ;
摘要
Objective:To study the relationship of the expressions of p53 and mdm2 in leukoplakia cancer.Methods:RT-PCR was used to detect the mRNA of p53,mdm2 in patients with leukoplakia cancer.The frequencies of p53,mdm2 in peripheral blood were detected by flow cytometric analysis.Results:The expression of p53mRNA in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were 7.7%,27.3%,33.3%,56.8%,respectively.The frequencies of p53 in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were(0.3±0.1)%,(l.6±0.9)%,(1.9±1.1)%,(3.4±1.8)%.The expression of mdm2 mRNA in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were 0.0%,6.8%,11.1%,37.8%,respectively.The frequencies of mdm2 in normal oral mucosa,simple oral leukoplakia,no-simple oral leukoplakia and leukoplakia cancer were(0.1±0.1)%,(0.8±0.6)%,(1.2±0.8)%,(1.2±0.8)%.There was a positively correlation between p53 mRNA and mdm2 mRNA.Conclusions:The positive rate of p53 and mdm2 cells in the peripheral blood increases in patients with leukoplakia cancer tissue and has positive correlation with the severity of leukoplakia cancer.
引用
收藏
页码:831 / 834
页数:4
相关论文
共 50 条
  • [1] Expression and significance of p53 and mdm2 in patients with leukoplakia cancer
    Cui, Juan-Juan
    Han, Xiao-Lan
    Wang, Wei-Min
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2013, 6 (10) : 831 - 834
  • [2] Expression of p53 and mdm2 and their significance in recurrence of superficial bladder cancer
    Tuna, B
    Yörükoglu, K
    Tüzel, E
    Güray, M
    Mungan, U
    Kirkali, Z
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (05) : 323 - 328
  • [4] Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer
    Dong, Ming
    Ma, Gang
    Tu, Wei
    Guo, Ke-Jian
    Tian, Yu-Lin
    Dong, Yu-Ting
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (14) : 2162 - 2165
  • [5] The p53 and Mdm2 families in cancer
    Michael, D
    Oren, M
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) : 53 - 59
  • [6] MDM2 and p53 expression in ampullary adenocarcinomas
    Perysinakis, I.
    Leontara, V.
    Minaidou, E.
    Karambogias, C.
    Choreftaki, T.
    Zografos, G.
    Kouraklis, G.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S126 - S126
  • [7] Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations
    Günther, T
    Schneider-Stock, R
    Häckel, C
    Kasper, HU
    Pross, M
    Hackelsberger, A
    Lippert, H
    Roessner, A
    [J]. MODERN PATHOLOGY, 2000, 13 (06) : 621 - 626
  • [8] Clinical significance of mdm2 and p53 expression in bladder cancer - A comparison with cell proliferation and apoptosis
    Shiina, H
    Igawa, M
    Shigeno, K
    Yamasaki, Y
    Urakami, S
    Yoneda, T
    Wada, Y
    Honda, S
    Nagasaki, M
    [J]. ONCOLOGY, 1999, 56 (03) : 239 - 247
  • [9] Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma
    Wang, Lin
    Zhang, Xiao-Ying
    Xu, Ling
    Liu, Wen-Jun
    Zhang, Juan
    Zhang, Jian-Ping
    [J]. ONCOLOGY LETTERS, 2011, 2 (04) : 707 - 712
  • [10] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678